Ocular Therapeutix Inc.
Organization details
- Legal name
- Ocular Therapeutix Inc.
- Former names
- I-Therapeutix Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Bedford
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OCUL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001393434
Board of directors
-
Adrienne L. Graves · DirectorSince 2023
-
Antony C. Mattessich · Director · President and CEOSince 2023
-
Charles M. Warden · DirectorSince 2023
-
Jeffrey S. Heier · DirectorSince 2023
-
Leslie J. Williams · DirectorSince 2023
-
Merilee Raines · DirectorSince 2023
-
Pravin Dugel · Director · See RemarksSince 2024
-
Riad Sherif · DirectorSince 2026
-
Richard L. Lindstrom M.D. · DirectorSince 2023
-
Seung Suh Hong · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
86.9%
-
90.6%
Board connections
4 of this board's directors also sit on 6 other boards. 5 are in the same sector.
-
Aura Biosciences Inc. Same sectorvia Antony C. Mattessich
-
Harrow Inc. Same sectorvia Adrienne L. Graves
-
LENSAR Inc. Same sectorvia Richard L. Lindstrom M.D.
-
Opus Genetics Inc. Same sectorvia Adrienne L. Graves
-
TransMedics Group Inc. Same sectorvia Merilee Raines
- via Merilee Raines
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $461,354
- 1 purchase by 1 insider
- Sold, last 12 months
- $3,250,061
- 29 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Riad Sherif Director | Grant or award | +28,000 | — | — |
| Nov 5, 2026 | Saroj Namrata Officer (Chief Business Officer) | Open-market sale | −35,370 | $6.55 | $231,674 |
| Oct 8, 2026 | Anderman Todd Officer (Chief Legal Officer) | Open-market sale | −11,984 | $7.29 | $87,363 |
| Oct 2, 2026 | Jeffrey S. Heier Officer (Chief Scientific Officer) | Open-market sale | −10,869 | $7.05 | $76,626 |
| Oct 2, 2026 | Kaiser Peter Officer (Chief Development Officer) | Open-market sale | −9,990 | $7.05 | $70,430 |
| Aug 31, 2026 | Notman Donald Officer (Chief Operating Officer) | Open-market sale | −1,099 | $10.24 | $11,254 |
| Aug 25, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | −50,092 | — | — |
| Aug 25, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | +50,092 | — | — |
| Aug 24, 2026 | Pravin Dugel Director, Officer (See Remarks) | Open-market sale | −21,649 | $10.77 | $233,160 |
| Aug 24, 2026 | Jeffrey S. Heier Officer (Chief Scientific Officer) | Open-market sale | −3,296 | $10.78 | $35,531 |
| Aug 24, 2026 | Kaiser Peter Officer (Chief Development Officer) | Open-market sale | −3,035 | $10.77 | $32,687 |
| Aug 24, 2026 | Nayak Sanjay Officer (Chief Strategy Officer) | Open-market sale | −1,897 | $10.78 | $20,450 |
| Jun 16, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | −50,092 | — | — |
| Jun 16, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | +50,092 | — | — |
| Jun 10, 2026 | Charles M. Warden Director | Grant or award | +14,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Ocular Therapeutix Inc.
Who is the CEO of Ocular Therapeutix Inc.?
Antony C. Mattessich is Ocular Therapeutix Inc.'s President and CEO.
How many directors are on Ocular Therapeutix Inc.'s board?
Ocular Therapeutix Inc.'s board has 10 directors: Adrienne L. Graves, Antony C. Mattessich, Charles M. Warden, Jeffrey S. Heier, Leslie J. Williams, Merilee Raines, Pravin Dugel, Riad Sherif, Richard L. Lindstrom M.D. and Seung Suh Hong.
Are Ocular Therapeutix Inc. insiders buying or selling shares?
Over the last 12 months, Ocular Therapeutix Inc. insiders bought $461,354 of shares in 1 purchase and sold $3.3 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="ocular-therapeutix-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.